AmplifyBio | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
AmplifyBio

BRIEF

published on 07/30/2024 at 13:05, 3 months 22 days ago

AmplifyBio Partners with Lipid Nanoparticle Expert to Enhance Drug Delivery

AmplifyBio MRNA Therapeutics Drug Delivery Lipid Nanoparticles Stephen Burgess
PRESS RELEASE

published on 07/30/2024 at 13:00, 3 months 22 days ago

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
AmplifyBio partners with Stephen Burgess, Ph.D., bringing expertise in LNP formulations for efficient mRNA delivery. Collaboration enhances lipid-based technologies for mRNA therapeutics

AmplifyBio Lipid Nanoparticles Stephen Burgess LNP Formulations MRNA Delivery
BRIEF

published on 04/16/2024 at 13:05, 7 months 5 days ago

AmplifyBio and RNAV8 Bio Form Strategic Partnership for mRNA Therapeutic Development

Strategic Partnership AmplifyBio MRNA Therapeutics RNAV8 Bio GMP Manufacturing
PRESS RELEASE

published on 04/16/2024 at 13:00, 7 months 5 days ago

AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture
AmplifyBio and RNAV8 Bio partner to offer one-stop shop for mRNA therapeutics development, integrating design, optimization, and manufacturing capabilities

Development AmplifyBio MRNA Therapeutics RNAV8 Bio Partnering
PRESS RELEASE

published on 02/08/2024 at 13:00, 9 months 13 days ago

AmplifyBio CEO J. Kelly Ganjei Discusses Solutions for Reducing Costs and Risk in Advanced Therapy Manufacturing During Fireside Chat at Advanced Therapies Week
J. Kelly Ganjei, CEO of AmplifyBio, shared insights at Advanced Therapies Week on the evolution of manufacturing strategies and fundraising in cell and gene therapy development. The fireside chat panel discussed early commercialization, tech transfer, and AmplifyBio's hybrid outsourcing model

AmplifyBio Advanced Therapies Week Cell And Gene Therapy Manufacturing Strategies Hybrid Outsourcing Model
PRESS RELEASE

published on 02/01/2024 at 13:00, 9 months 20 days ago

AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio
AmplifyBio celebrates successful grand opening of AMEC, showcasing manufacturing suites and operating models for advanced therapies. Executives and key speakers highlight the milestone event's significance

AmplifyBio AMEC Manufacturing Suites Advanced Therapies Milestone Event
PRESS RELEASE

published on 11/28/2023 at 13:00, 11 months 23 days ago

AmplifyBio Expands Its Vision: Launches Advanced Therapy Manufacturing Enablement Center in New Albany, Ohio
PRESS RELEASE

published on 11/07/2023 at 13:00, 1 year ago

AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
PRESS RELEASE

published on 10/31/2023 at 12:00, 1 year ago

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics
PRESS RELEASE

published on 07/12/2023 at 13:00, 1 year 4 months ago

AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients

Accesswire

Published on 11/21/2024 at 13:30, 33 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 33 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 48 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 28 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 48 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 56 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 3 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 43 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE